October can often be a volatile month due to various factors like earnings reports and economic data releases. The volatility we’ve witnessed this October is largely driven by heightened geopolitical tensions, particularly the ongoing conflict in the Middle East.
Gland Pharma shares zoom 12% post Q2 results; Kotak upgrades on limited downside
Gland Pharma Share Price: Gland Pharma shares rose 12% despite a 15.7% YoY profit decline in Q2. Kotak upgraded the stock to ‘Reduce’ with a